Formedix is Joining in the Conversation

It is a busy time of year for Formedix, the leading provider of clinical trial automation tools, with various conferences and speaking opportunities taking place recently and coming up.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
CDASH can make life a lot easier - managing your metadata, as well as making mapping of collection variables to the SDTM domains less time-consuming.

Burlington, MA (PRWEB) October 02, 2013

Once again, Formedix was exhibiting at this year’s Society of Clinical Data Management Annual Conference in Chicago, IL. As ‘the world’s largest education event for clinical data managers and related professionals,’ the conference gave attendees the opportunity to hear from industry experts, as well as the chance to speak to various software and services providers, including Formedix. Formedix offers universal design and execution solutions for your end-to-end clinical trials.

As a true CDISC expert and advocate having worked with the standards since 2000, Formedix CEO Mark Wheeldon was invited to speak at the New Jersey CDISC User Group, held on Thursday, September 19, at Merck in Summit. Mark was discussing all things CDASH, how the standard works with multi-EDC vendors and how it can be implemented throughout the end-to-end clinical trial process. His presentation was part of a full meeting agenda including discussions on the automation of ADaM dataset creation and working with value-level metadata in Define.xml v2.0.

On the topic of CDASH, Mark Wheeldon says, “As a growing part of a number of CDISC content standards, CDASH is designed to originate the collection of content aligned end-to-end through to submission of data. However, very few people are adopting CDASH from study setup and throughout the entire trial. CDASH can make life a lot easier - managing your metadata, as well as making mapping of collection variables to the SDTM domains less time-consuming.” To access the full User Group meeting program, visit the event page.

Formedix has also been invited to present at the upcoming European Medidata User Group conference taking place in Florence on October 14-16, 2013. As part of an agenda developed by a customer/partner led Organizing Committee, Mark will be discussing ‘True end-to-end CDISC implementation with Rave’ looking at the significant levels of Rave build automation that are now possible. Formedix has established relationships with leading EDC vendors, including Medidata, to develop Transform tools, in this case, Transform for Rave, which creates and visualizes studies within multiple EDC systems.

In addition, on November 4-8, 2013, the Annual CDISC International Interchange will be taking place in Bethesda, MD. Formedix is exhibiting again this year at the conference, as well as Mr Wheeldon being invited to present. His presentation will look at ‘A 10 Year Journey of Innovation: Implementing CDISC Standards to Save Time and Money,’ discussing CDISC foundational models and content standards as well as innovative new standards coming from NCI, CFAST and TransCelerate. Mark’s talk will discuss secrets to using CDISC across the end-to-end clinical trial process rather than solely adopting standards due to regulatory requirement. To find out more about the conference program, visit the CDISC website.

For more information about Formedix public appearances, please contact Formedix.

If you would like more information about Formedix software and services, please visit the website.

About Formedix

Formedix clinical trial automation software and services enable you to remove manual, expensive, inefficient and labor intensive tasks from study set-up, EDC build, validation and submission publication processes.

In fact, across every area of your end-to-end clinical trial, the time and cost savings they deliver speak for themselves and continue to do so time and time again...

Formedix saves 68% in set-up time and 55% in EDC build time. With 70% reuse of your content, resources are cut by 23%. It’s all in the numbers.


Contact